Alcon Inc. ALC
Set alert
At close · Nov 2
After hours · Nov 2, 4:23 PM ET
- YTD
- -6.57%
- 1 year
- -0.35%
- Open
- 72.06
- Prev close
- 71.45
- Mkt cap
- 35.59B
- Vol
- 2.20M
- Avg vol
- 1.68M
- EPS
- 1.32
- P/E
- 55.78
- Div yield
- 0.50%
More statistics
- Low
- 72.05
- High
- 74.19
- Forward P/E
- 18.62
- Beta
- 0.72
- Short ratio
- 10.62
- Inst. own
- 62.51%
- Dividend
- 0.36
- Ex-div date
- May 5, 2026
- Earnings
- Nov 10, 2026
- 50-d avg
- 67.64
- 200-d avg
- 71.95
- 1y target
- 81.98
5Y chart
Events in this range
- Apr 29, 2022Dividend: 0.13
- May 3, 2022Dividend: 0.205
- May 9, 2023Dividend: 0.1365
- May 10, 2023Dividend: 0.23574
- May 14, 2024Dividend: 0.2647
- May 13, 2025Dividend: 0.3334
- May 14, 2025Dividend: 0.3334
- Aug 19, 2025Earnings: 0.76; estimate 0.71; surprise 7.04%
- Nov 11, 2025Earnings: 0.79; estimate 0.77; surprise 2.6%
- Feb 24, 2026Earnings: 0.78; estimate 0.79; surprise -1.27%
- May 5, 2026Dividend: 0.23203
- May 5, 2026Earnings: 0.85; estimate 0.8; surprise 6.25%
- May 6, 2026Dividend: 0.3593
- Aug 10, 2026Earnings: 0.84; estimate 0.77; surprise 9.09%
- Sep 22, 2026Rating: Jefferies · Buy → Buy
- Oct 7, 2026Rating: Barclays · — → Equal-Weight
- Oct 12, 2026Rating: BTIG · Buy → Buy
- Oct 21, 2026Rating: Needham · Buy → Buy
- Oct 27, 2026Rating: Keybanc · Overweight → Overweight
- Nov 2, 2026Rating: Needham · Buy → Buy
Signals (98)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 19, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 16, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bullish | Feb 16, 2026 | 8 months ago |
| SMA: Bullish | Feb 16, 2026 | 8 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| SMA: Bullish | Jan 19, 2026 | 9 months ago |
| SMA: Bullish | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 17, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| SMA: Bearish | Aug 18, 2025 | 1 year ago |
| SMA: Bullish | Aug 11, 2025 | 1 year ago |
| SMA: Bearish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| MACD: Sell Signal | May 19, 2025 | 1 year ago |
| SMA: Bearish | May 12, 2025 | 1 year ago |
| SMA: Bullish | Apr 14, 2025 | 1 year ago |
| SMA: Bullish | Apr 14, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| SMA: Bullish | Mar 24, 2025 | 1 year ago |
| SMA: Bullish | Mar 17, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| SMA: Bullish | Feb 24, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 3, 2025 | 1 year ago |
| SMA: Bullish | Jan 20, 2025 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bearish | Oct 14, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 14, 2024 | 2 years ago |
| RSI: Overbought | Aug 26, 2024 | 2 years ago |
| SMA: Bullish | May 13, 2024 | 2 years ago |
| MACD: Buy Signal | May 13, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 22, 2024 | 2 years ago |
| SMA: Bearish | Apr 8, 2024 | 2 years ago |
| SMA: Bullish | Feb 12, 2024 | 2 years ago |
| SMA: Bullish | Feb 5, 2024 | 2 years ago |
| SMA: Bearish | Jan 22, 2024 | 2 years ago |
| SMA: Bearish | Jan 15, 2024 | 2 years ago |
| SMA: Bullish | Jan 8, 2024 | 2 years ago |
| MACD: Buy Signal | Dec 25, 2023 | 2 years ago |
| SMA: Bullish | Dec 11, 2023 | 2 years ago |
| SMA: Bearish | Dec 4, 2023 | 2 years ago |
| SMA: Bullish | Nov 27, 2023 | 2 years ago |
| SMA: Bearish | Sep 25, 2023 | 3 years ago |
| SMA: Bearish | Aug 28, 2023 | 3 years ago |
| SMA: Bullish | Aug 14, 2023 | 3 years ago |
| MACD: Sell Signal | Aug 14, 2023 | 3 years ago |
| SMA: Bearish | Jul 31, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 17, 2023 | 3 years ago |
| SMA: Bullish | Apr 3, 2023 | 3 years ago |
| SMA: Bullish | Mar 20, 2023 | 3 years ago |
| SMA: Bearish | Mar 6, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 6, 2023 | 3 years ago |
| SMA: Bearish | Feb 20, 2023 | 3 years ago |
| SMA: Bullish | Dec 19, 2022 | 3 years ago |
| SMA: Bearish | Dec 12, 2022 | 3 years ago |
| SMA: Bullish | Nov 21, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 14, 2022 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| MACD: Sell Signal | Aug 29, 2022 | 4 years ago |
| SMA: Bearish | Aug 8, 2022 | 4 years ago |
| SMA: Bearish | Aug 8, 2022 | 4 years ago |
| SMA: Bullish | Jul 25, 2022 | 4 years ago |
| SMA: Bullish | Jul 18, 2022 | 4 years ago |
| SMA: Bearish | Jul 11, 2022 | 4 years ago |
| MACD: Buy Signal | Jul 4, 2022 | 4 years ago |
| SMA: Bullish | Jun 27, 2022 | 4 years ago |
| SMA: Bearish | Jun 6, 2022 | 4 years ago |
| SMA: Bullish | May 23, 2022 | 4 years ago |
| SMA: Bearish | Apr 25, 2022 | 4 years ago |
| SMA: Bullish | Apr 18, 2022 | 4 years ago |
| SMA: Bearish | Apr 11, 2022 | 4 years ago |
| SMA: Bullish | Mar 28, 2022 | 4 years ago |
| SMA: Bearish | Mar 21, 2022 | 4 years ago |
| SMA: Bullish | Mar 14, 2022 | 4 years ago |
Key statistics
- Market cap
- 35.59B
- Enterprise value
- 38.38B
- Trailing P/E
- 55.77
- Forward P/E
- 18.62
- PEG ratio
- 1.29
- Price / sales
- 3.28
- Price / book
- 1.65
- EPS (TTM)
- 1.32
- Beta
- 0.72
- Dividend yield
- 0.50%
- Payout ratio
- 26.56%
- Profit margin
- 5.92%
- Revenue (TTM)
- 10.86B
- Revenue growth
- 8.70%
- Free cash flow
- 1.27B
- Total cash
- 1.46B
- Total debt
- 5.30B
- Return on equity
- 2.94%
- Shares outstanding
- 483.40M
- Short % of float
- 0.00%
- 50-day average
- 67.64
- 200-day average
- 71.95
Analyst view
Consensus: buy
- Target (low)
- 62.00
- Target (mean)
- 81.98
- Target (high)
- 103.00
- Strong buy4
- Buy17
- Hold5
- Sell0
- Strong sell1
Next earnings
Nov 10, 2026
Expected Nov 10, 2026. Consensus EPS estimate 0.89001.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 10, 2026 | Sep 30, 2026 | 0.89 | — | — | — |
| Aug 10, 2026 | Jun 30, 2026 | 0.77 | 0.84 | +0.07 | +9.09% |
| May 5, 2026 | Mar 31, 2026 | 0.80 | 0.85 | +0.05 | +6.25% |
| Feb 24, 2026 | Dec 31, 2025 | 0.79 | 0.78 | -0.01 | -1.27% |
| Nov 11, 2025 | Sep 30, 2025 | 0.77 | 0.79 | +0.02 | +2.60% |
| Aug 19, 2025 | Jun 30, 2025 | 0.71 | 0.76 | +0.05 | +7.04% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Needham | reit | Buy | Buy |
| Oct 27, 2026 | Keybanc | main | Overweight | Overweight |
| Oct 21, 2026 | Needham | reit | Buy | Buy |
| Oct 12, 2026 | BTIG | main | Buy | Buy |
| Oct 7, 2026 | Barclays | init | — | Equal-Weight |
| Sep 22, 2026 | Jefferies | main | Buy | Buy |
About Alcon Inc.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- Switzerland
- Website
- alcon.com
News
- Keybanc Maintains Overweight on Alcon, Lowers Price Target to $84
- Alcon Sees Another Bullish Rating After Clear Portfolio Growth Direction In Eyecare
- Alcon Acquires Neurotech Pharmaceuticals For $550M
- Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
- Algoma Central Corporation Announces $62.5 million Offering of 6.20% Convertible Unsecured Subordinated Debentures
- FDA Approves Alcon's BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
- Alcon Announces FDA Approval For BRYTLY Redness Relief Eye Drops, Expanding Over The Counter Eye Care Portfolio.
- FDA Approves Alcon's BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
- Credo Expands AI Connectivity Portfolio With 1.6T ZeroFlap ALC
- Credo Unveils 1.6T ZeroFlap Active Light Cable, Industry's First Row-Scale, Wide-Parallel Optical Interconnect for AI Data Centers
Your note
Sign in to keep a note on ALC — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 2.95% | 14,749,582 | 1.09B | Jun 29, 2026 |
| Bank Of New York Mellon Corporation | 2.61% | 13,057,962 | 961.33M | Jun 29, 2026 |
| NORGES BANK | 2.20% | 10,976,697 | 808.10M | Jun 29, 2026 |
| Invesco Ltd. | 2.08% | 10,380,332 | 764.20M | Jun 29, 2026 |
| Aristotle Capital Management, LLC | 2.00% | 9,979,069 | 734.66M | Jun 29, 2026 |
| AKO Capital LLP | 1.94% | 9,683,004 | 712.86M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund | 1.44% | 7,175,218 | 528.24M | Jul 30, 2026 |
| VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund | 0.95% | 4,758,876 | 350.35M | Jun 29, 2026 |
| iShares Trust-iShares Core MSCI EAFE ETF | 0.75% | 3,735,153 | 274.98M | Sep 29, 2026 |
| ALLSPRING FUNDS TRUST-Allspring Special Mid Cap Value Fund | 0.66% | 3,283,650 | 241.74M | Aug 30, 2026 |
| VANGUARD WINDSOR FUNDS-Vanguard Windsor II Fund | 0.58% | 2,918,000 | 214.82M | Jul 30, 2026 |
| MFS SERIES TRUST X-MFS International Intrinsic Equity Fund | 0.48% | 2,417,516 | 177.98M | Aug 30, 2026 |